Marka sorgulama · Bülten 369

elevidys

SAREPTA THERAPEUTICS, INC.

Tescilli Başvuru no 2021/031621 · 13 Ekim 2020 · vekilsiz başvuru

Süreç

  1. Başvuru 13 Ekim 2020
  2. Bültende yayın Resmî Marka Bülteni 369 · 29 Mart 2021
  3. İtiraz penceresi (2 ay) Son gün 29 Mayıs 2021 · kapandı
  4. Tescil Tescil no 2021 031621· Gazete 472 (30 Temmuz 2021)
  5. Yenileme Koruma 10 yıl: yenileme tarihi Ekim 2030 (son 6 ay içinde başvurulur).

Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.

Bu marka senin mi? Benzer bir başvuru bültene düştüğü gün e-posta alırsın; ilk marka ücretsiz. Web'de ya da uygulamada.

Sınıflar ve kapsam

Mal ve hizmet listesi

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; pharmaceutical preparations that modulate rna expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs, all of the foregoing used as delivery agents, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases.

Aynı bültende benzer başvurular

Bülten 369 içindeki 729 aynı-sınıf başvuru arasında Nomist'in benzerlik algoritmasına takılan yok.

Aynı adı taşıyan diğer markalar

SAREPTA THERAPEUTICS, INC.
2023/149968
Tescilli 5 41 44